• Prof. Helen McShane (chair)
    Prof. Helen McShane (chair)Wellcome Trust Senior Clinical Research Fellow Professor of Vaccinology University of Oxford Oxford, United Kingdom
    • Prof. Peter Andersen, DVM, DMSc
      Prof. Peter Andersen, DVM, DMScVice President of Vaccine Research and Development Statens Serum Institut Copenhagen, Denmark
      • Dr Carol Holm-Hansen
        Dr Carol Holm-HansenSenior scientist Norwegian Institute of Public Health Oslo, Norway
        • Prof. Dr Dr h.c. Stefan H.E. Kaufmann
          Prof. Dr Dr h.c. Stefan H.E. KaufmannFounding Director Max-Planck-Institute for Infection Biology Berlin, Germany
          • Prof. Willem Hanekom
            Prof. Willem HanekomDeputy Director tuberculosis Bill & Melinda Gates Foundation Seattle, USA
            • Prof. Michel Kazatchkine, MD
              Prof. Michel Kazatchkine, MDSenior Fellow, Global Health Programme, Graduate Institute of International and Development Studies
              • Dr Camille Locht
                Dr Camille LochtResearch Director, French National Institute of Health and Medical Research (Inserm) Head of the Center for Infection and Immunity of Lille, Institut Pasteur de Lille, France.
                • Prof. Carlos Martin
                  Prof. Carlos MartinProfessor of Microbiology University of Zaragoza Zaragoza, Spain
                  • Dr Olivier Neyrolles
                    Dr Olivier NeyrollesCNRS Research Director Institute of Pharmacology & Structural Biology Toulouse, France
                    • Dr Gerd Zettlmeissl
                      Dr Gerd ZettlmeisslRepresentative of the Board of Directors of Aeras Former CEO Valneva SE (formerly Intercell AG) Vienna, Austria
                      • Dr Ann Rawkins
                        Dr Ann RawkinsTB project co-ordinator, Health Protection England
                        • Prof. Hazel M. Dockrell
                          Prof. Hazel M. DockrellProfessor of Immunology, Special Advisor on Overseas Partnerships in Africa, London School of Hygiene and Tropical Medicine, UK
                          • Dr Geneviève Inchauspé
                            Dr Geneviève InchauspéHead of the Department of Infectious Diseases, Transgene, Lyon, France
                            • Ingrid Murillo Jelsbak
                              Ingrid Murillo JelsbakClinical Research Director at Biofabri, Porriño, Spain
                              • Dr Jan T. Poolman
                                Dr Jan T. PoolmanHead Bacterial Vaccine Discovery and Early Development at the Janssen Pharmaceutical Companies of Johnson & Johnson, Leiden, The Netherlands
                                • Marie-Ange Demoitié
                                  Marie-Ange DemoitiéTB Vaccine Project Leader, Vaccines Discovery & Development, GSK
                                  • Olga Rué Clarós
                                    Olga Rué ClarósCEO Archivel Farma S.L. Badalona (Barcelona), Spain.